Regeneron, Sanofi Skin Cancer Drug Gets Warm Reception from European Regulators

Date : 04/26/2019 @ 5:48PM
Source : Dow Jones News
Stock : Regeneron Pharmaceuticals Inc (REGN)
Quote : 300.77  0.0 (0.00%) @ 12:14PM

Regeneron, Sanofi Skin Cancer Drug Gets Warm Reception from European Regulators

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart

6 Months : From Apr 2019 to Oct 2019

Click Here for more Regeneron Pharmaceuticals Charts.

By Kimberly Chin


Regeneron Pharmaceuticals Inc. (REGN) and Sanofi SA (SAN.FR) said a European regulatory panel had issued a positive opinion and recommended conditional approval for their drug that treats patients with a common type of skin cancer.

If the drug, Libtayo, wins approval from the European Commission, it would be the first and only treatment for some patients with an advanced form of carcinoma in Europe.

Libtayo, which is jointly developed by Regeneron and Paris-based Sanofi, is a prescription medicine that treats carcinoma patients with who cannot be cured by surgery or radiation.

The companies said they will need to provide regulators with additional data from a new group trial to help confirm the benefits and risk profile of the drug.

European regulators could make a final decision on Libtayo within the coming months, the companies said.

Shares of Regeneron were down 2.5%, while shares of Sanofi rose 3.5% on Friday.


Write to Kimberly Chin at


(END) Dow Jones Newswires

April 26, 2019 12:33 ET (16:33 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest REGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.